Vasopressin and terlipressin in adult vasodilatory shock
1 Department of Cardiology, Bambino Gesù Children's Hospital, Piazza S. Onofrio 4, 00165 Rome, Italy
2 Center for Nano Science and Technology @ POLIMI, Istituto Italiano di Tecnologia, Via G. Pascoli 70/3, Milano 20133, Italy
3 Critical Care Department, Hôpital Raymond Poincare (Assistance Publique-Hôpitaux de Paris), University of Versailles, Garches 92380, France
Critical Care 2012, 16:470 doi:10.1186/cc11887
See related research by Serpa Neto et al., http://ccforum.com/content/16/4/R154Published: 28 December 2012
First paragraph (this article has no abstract)
We have read with interest the study by Serpa Neto and colleagues showing that vasopressin use in vasodilatory shock is associated with reduced mortality . However, we believe there are three aspects that need clarification.